

Inogen (NASDAQ:INGN) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Inogen (NASDAQ:INGN) through any online brokerage.
Other companies in Inogen’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Inogen has a consensus price target of $10.40.
The stock price for Inogen (NASDAQ: INGN) is $5.91 last updated November 6, 2026 at 7:02 PM EST.
There are no upcoming dividends for Inogen.
Inogen does not have any upcoming earnings scheduled.
There is no upcoming split for Inogen.
Inogen is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen...